A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo

Archives of Dermatology

Volumn 142, Issue 7, 2006, Pages 927-929

  Mehrabi, Don ^b   Pandya, Amit G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT; PETROLATUM; PLACEBO; TACROLIMUS;

ANAMNESIS; ARTICLE; ATOPIC DERMATITIS; BLISTER; BODY REGIONS; BODY SURFACE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ERYTHEMA; HEALTH PRACTITIONER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL INSTRUMENTATION; OINTMENT; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SCREENING; SKIN CANCER; SKIN DEFECT; STATISTICAL ANALYSIS; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO;

ADMINISTRATION, CUTANEOUS; DOUBLE-BLIND METHOD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PUVA THERAPY; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY; VITILIGO;

EID: 33746043008     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.7.927     Document Type: Article

References (8)

1. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol. 2001;44:999-1003.
2. Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol. 2004;51:52-61.
3. Tanghetti EA. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis. 2003;71:158-162.
4. Silverberg NB, Lin P, Travis L. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol. 2004:51:760-766.
5. Castanedo-Cazares JP, Lepe V, Moncada B. Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band. Photodermatol Photoimmunol Photomed. 2003;19:35-36.
6. Protopic [package insert]. Deerfield, Ill: Fujisawa Healthcare Inc; December 2000.
7. Schallreuter KU, Tobin DJ, Panske A. Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed caucasian patients with vitiligo. Dermatology. 2002;204:194-201.
8. Oettlè AG. Skin cancer in Africa. Natl Cancer Inst Monogr. 1963;10:197-214.